Skip to main content
Clinical Trials/NCT02120599
NCT02120599
Completed
Not Applicable

Randomized Controlled Trial of the Impact of Treating Moderately Malnourished Women in Pregnancy

Washington University School of Medicine2 sites in 1 country1,867 target enrollmentMarch 2014

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Pregnancy
Sponsor
Washington University School of Medicine
Enrollment
1867
Locations
2
Primary Endpoint
Maternal change in mid-upper arm circumference (MUAC)
Status
Completed
Last Updated
9 years ago

Overview

Brief Summary

Malnutrition during pregnancy is more common in poor women in the developing world due to inadequate dietary intake combined with increased nutrient requirements; pregnancy risk is more consequential than among other demographic groups with increased risk of maternal and infant mortality and the lifelong effects of fetal malnutrition. The benefits of treating moderate malnutrition during pregnancy remain largely undocumented. This study tests the hypothesis that providing either a fortified flour or fortified paste-based supplementary food designed to replete the nutrient deficits during pregnancy will result in improved maternal nutritional recovery rates and higher infant birth weights and lengths. This study is a randomized, controlled clinical trial of 3 supplementary foods in 1800 moderately malnourished Malawian women who are pregnant. Subjects will receive one of 3 food rations: 1) a ready-to-use supplementary food formulated to deliver about 200% of the recommended daily allowance (RDA) of most micronutrients in pregnancy (RUSF-P), 2) corn soy blend with a multiple micronutrient tablet chosen to deliver about 200% of the RDA of most micronutrients (CSB-P) or 3), the standard of care which is a corn soy blend with supplementary iron and folic acid (CSB), delivering between 0-350% of the RDA. Subjects will receive the supplementary food until they recover from MAM. The outcome of the pregnancy and maternal nutritional status will be followed until 3 months after delivery.

Registry
clinicaltrials.gov
Start Date
March 2014
End Date
August 2016
Last Updated
9 years ago
Study Type
Interventional
Study Design
Parallel
Sex
Female

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Pregnant and consenting to study participation and HIV testing (if not already performed)
  • mid-upper-arm circumference (MUAC) ≤ 23 cm
  • planning to stay in the area and attend the clinic during pregnancy and for 3 months post partum

Exclusion Criteria

  • Pregnancy complications such as gestational diabetes, pre-eclampsia, hypertension
  • Severe anemia (Hg \<7.0 mg/dl)
  • Severe malnutrition
  • under 18 years of age
  • over estimated 35 weeks of gestation

Outcomes

Primary Outcomes

Maternal change in mid-upper arm circumference (MUAC)

Time Frame: up to 40 weeks

average change in mid-upper-arm circumference

infant birth weight

Time Frame: up to 40 weeks

mean birth weights of infants born to mothers in the study

Proportion recovered from moderate acute malnutrition (MAM)

Time Frame: up to 40 weeks

proportion of women who reach mid-upper arm circumference (MUAC) \> 23.5 cm for 2 consecutive visits

premature delivery

Time Frame: up to 36 weeks

proportion of infants born prematurely

infant birth length

Time Frame: up to 40 weeks

mean birth length of infants born to women in the study

Secondary Outcomes

  • pregnancy complications(up to 40 weeks)
  • maternal weight gain(up to 40 weeks)
  • infant length at 3 months(3 months)
  • maternal hemoglobin(8 weeks)
  • infant survival at 3 months(3 months)
  • infant weight at 3 months(3 months)

Study Sites (2)

Loading locations...

Similar Trials